130
Participants
Start Date
September 11, 2024
Primary Completion Date
December 17, 2032
Study Completion Date
December 17, 2032
REGV131
Single dose administered via intravenous (IV) infusion before LNP1265
LNP1265
Single dose administered via IV infusion following REGV131
RECRUITING
Royal Prince Alfred Hospital, Haemophilia Treatment Centre, Camperdown
RECRUITING
Complejo Hospitalario Universitario de A Coruna, A Coruña
RECRUITING
Children's Hospital of Philadelphia (CHOP), Philadelphia
RECRUITING
University Hospital Hamburg Eppendorf, Hamburg
RECRUITING
Hospital Universitario La Paz, Madrid
RECRUITING
Hospital Clinico Universitario Virgen De La Arrixaca, El Palmar
RECRUITING
Hospital Universitario Central de Asturias, Oviedo
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
Haemostasis and Thrombosis Unit, Hospital La Fe, Valencia
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Hospital Universitario Miguel Servet, Zaragoza
RECRUITING
University Hospital Frankfurt, Frankfurt am Main
RECRUITING
Hospices Civils de Lyon, Bron
RECRUITING
Tulane University School of Medicine, Louisiana Center for Bleeding and Clotting Disorders, New Orleans
RECRUITING
Hopital Necker, Paris
RECRUITING
Orthopaedic Hemophilia Treatment Center, Los Angeles
RECRUITING
David Geffen School of Medicine at UCLA, Los Angeles
RECRUITING
Children's Hospital Los Angeles, Los Angeles
RECRUITING
University California San Francisco, San Francisco
RECRUITING
University of California Davis, Sacramento
RECRUITING
Yale HTC, New Haven
RECRUITING
McMaster University Medical Centre - Hamilton Health Sciences, Hamilton
RECRUITING
Hospital Universitario Vall d'Hebron, Barcelona
RECRUITING
Glasgow Royal Infirmary - Clinical Research Facility, Glasgow
RECRUITING
Queen Elizabeth Hospital Birmingham, Birmingham
RECRUITING
Addenbrooke's Hospital, Cambridge University Hospitals NHS FT, Cambridge
RECRUITING
Pathology and Pharmacy Building, The Royal London Hospital, London
RECRUITING
Royal Free London NHS Foundation Trust, London
RECRUITING
St. Thomas' Hospital, London
RECRUITING
Hammersmith Hospital Comprehensive Care Centre, London
Collaborators (1)
Intellia Therapeutics
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY